Calcium Compound with Hydrogen Therapy May Reduce Bone Infections in Lab Tests
Bioactive Calcium Hydride-Driving "Triple" Hydrogen/Alkaline/Calcium Therapy for Efficient Treatment of Osteomyelitis
Research hubs: Musculoskeletal System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (cell culture)
- Authors
- Lin Chen, Shuning Cheng, Shunyi Lu, Xiang Gao, Fei Gong, Junwu Shi, Zhihui Han, Yuanjie Wang, Xiaoyuan Yang, Xiaozhong Zhou, Liang Cheng
- Journal
- Small
- Year
- 2024
- PMID
- 39444214
- Study Type
- Cell Culture
- Delivery
- Gas (Sustained Release)
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 12 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Scientists have found that calcium hydride (CaH2) can effectively kill bacteria causing bone infections and promote bone healing without relying on antibiotics.
Key Finding
Calcium hydride killed bacteria and promoted bone healing in infected mouse bones through three simultaneous mechanisms: generating an alkaline environment, delivering calcium ions, and producing hydrogen gas.
Summary
Researchers tested calcium hydride, a compound that releases hydrogen gas, alkaline chemicals, and calcium ions when exposed to water, as a potential treatment for osteomyelitis (a serious bone infection caused by bacteria). In laboratory and mouse studies, calcium hydride killed bacteria through multiple mechanisms: it created an alkaline environment toxic to bacteria, caused calcium buildup inside bacterial cells, and generated hydrogen gas that damaged bacterial membranes. When applied to infected mouse bones, the treatment reduced bacteria, decreased inflammation, and promoted new bone growth.
Practical Takeaway
This is early-stage research conducted in laboratory and animal models only, not in humans. While the results are promising for a potential future treatment of antibiotic-resistant bone infections, it is far too premature to draw any conclusions about whether hydrogen water or similar products would have similar effects in people. Much more research, including human clinical trials, would be needed before any therapeutic claims could be made.
Abstract (excerpt)
Abstract Osteomyelitis with high mortality and disability rates is a common clinical disease caused by a bacterial infection that is difficult to cure. Considering the stubborn nature and depth of tissue infection, rapid and effective treatments for osteomyelitis remain an enormous challenge…